377 related articles for article (PubMed ID: 17257132)
1. OLIG2 is a useful immunohistochemical marker in differential diagnosis of clear cell primary CNS neoplasms.
Preusser M; Budka H; Rössler K; Hainfellner JA
Histopathology; 2007 Feb; 50(3):365-70. PubMed ID: 17257132
[TBL] [Abstract][Full Text] [Related]
2. Comparative analysis of NeuN immunoreactivity in primary brain tumours: conclusions for rational use in diagnostic histopathology.
Preusser M; Laggner U; Haberler C; Heinzl H; Budka H; Hainfellner JA
Histopathology; 2006 Mar; 48(4):438-44. PubMed ID: 16487366
[TBL] [Abstract][Full Text] [Related]
3. Olig2 expression, GFAP, p53 and 1p loss analysis contribute to glioma subclassification.
Mokhtari K; Paris S; Aguirre-Cruz L; Privat N; Crinière E; Marie Y; Hauw JJ; Kujas M; Rowitch D; Hoang-Xuan K; Delattre JY; Sanson M
Neuropathol Appl Neurobiol; 2005 Feb; 31(1):62-9. PubMed ID: 15634232
[TBL] [Abstract][Full Text] [Related]
4. Value and limits of immunohistochemistry in differential diagnosis of clear cell primary brain tumors.
Koperek O; Gelpi E; Birner P; Haberler C; Budka H; Hainfellner JA
Acta Neuropathol; 2004 Jul; 108(1):24-30. PubMed ID: 15108012
[TBL] [Abstract][Full Text] [Related]
5. A distinct pattern of Olig2-positive cellular distribution in papillary glioneuronal tumors: a manifestation of the oligodendroglial phenotype?
Tanaka Y; Yokoo H; Komori T; Makita Y; Ishizawa T; Hirose T; Ebato M; Shibahara J; Tsukayama C; Shibuya M; Nakazato Y
Acta Neuropathol; 2005 Jul; 110(1):39-47. PubMed ID: 15906048
[TBL] [Abstract][Full Text] [Related]
6. Challenging diagnosis: oligodendroglioma versus extraventricular neurocytoma.
Mut M; Güler-Tezel G; Lopes MB; Bilginer B; Ziyal I; Ozcan OE
Clin Neuropathol; 2005; 24(5):225-9. PubMed ID: 16167546
[TBL] [Abstract][Full Text] [Related]
7. Utility of in situ demonstration of 1p loss and p53 overexpression in pathologic diagnosis of oligodendroglial tumors.
Hirose T; Ishizawa K; Shimada S
Neuropathology; 2010 Dec; 30(6):586-96. PubMed ID: 20408960
[TBL] [Abstract][Full Text] [Related]
8. Olig2 is useful in the differential diagnosis of oligodendrogliomas and extraventricular neurocytomas.
Okada M; Yano H; Hirose Y; Nakayama N; Ohe N; Shinoda J; Iwama T
Brain Tumor Pathol; 2011 Apr; 28(2):157-61. PubMed ID: 21312066
[TBL] [Abstract][Full Text] [Related]
9. Diversity of glial cell components in pilocytic astrocytoma.
Tanaka Y; Sasaki A; Ishiuchi S; Nakazato Y
Neuropathology; 2008 Aug; 28(4):399-407. PubMed ID: 18312545
[TBL] [Abstract][Full Text] [Related]
10. Systematic immunohistochemical profiling of 378 brain tumors with 37 antibodies using tissue microarray technology.
Ikota H; Kinjo S; Yokoo H; Nakazato Y
Acta Neuropathol; 2006 May; 111(5):475-82. PubMed ID: 16598485
[TBL] [Abstract][Full Text] [Related]
11. Genetic differences between neurocytoma and dysembryoplastic neuroepithelial tumor and oligodendroglial tumors.
Fujisawa H; Marukawa K; Hasegawa M; Tohma Y; Hayashi Y; Uchiyama N; Tachibana O; Yamashita J
J Neurosurg; 2002 Dec; 97(6):1350-5. PubMed ID: 12507133
[TBL] [Abstract][Full Text] [Related]
12. Olig2 and CD99 are useful negative markers for the diagnosis of brain tumors.
Ishizawa K; Komori T; Shimada S; Hirose T
Clin Neuropathol; 2008; 27(3):118-28. PubMed ID: 18552083
[TBL] [Abstract][Full Text] [Related]
13. Glycogen-rich pleomorphic xanthoastrocytoma with clear-cell features: confirmatory report of a rare variant with implications for differential diagnosis.
Vajtai I; Stibal A; von Gunten M; Kappeler A; Vassella E; Frank S
Pathol Res Pract; 2011 Apr; 207(4):256-61. PubMed ID: 21282017
[TBL] [Abstract][Full Text] [Related]
14. Ependymomas of the central nervous system and adult extra-axial ependymomas are morphologically and immunohistochemically distinct--a comparative study with assessment of ovarian carcinomas for expression of glial fibrillary acidic protein.
Idowu MO; Rosenblum MK; Wei XJ; Edgar MA; Soslow RA
Am J Surg Pathol; 2008 May; 32(5):710-8. PubMed ID: 18360284
[TBL] [Abstract][Full Text] [Related]
15. A case of oligodendroglioma with prominent neuronal differentiation.
Hirose T; Nobusawa S; Nakazato Y; Sasaki A
Hum Pathol; 2013 Oct; 44(10):2353-9. PubMed ID: 24054724
[TBL] [Abstract][Full Text] [Related]
16. NeuN expression correlates with reduced mitotic index of neoplastic cells in central neurocytomas.
Englund C; Alvord EC; Folkerth RD; Silbergeld D; Born DE; Small R; Hevner RF
Neuropathol Appl Neurobiol; 2005 Aug; 31(4):429-38. PubMed ID: 16008827
[TBL] [Abstract][Full Text] [Related]
17. Chlorotoxin, a scorpion-derived peptide, specifically binds to gliomas and tumors of neuroectodermal origin.
Lyons SA; O'Neal J; Sontheimer H
Glia; 2002 Aug; 39(2):162-73. PubMed ID: 12112367
[TBL] [Abstract][Full Text] [Related]
18. OLIG2 as a specific marker of oligodendroglial tumour cells.
Marie Y; Sanson M; Mokhtari K; Leuraud P; Kujas M; Delattre JY; Poirier J; Zalc B; Hoang-Xuan K
Lancet; 2001 Jul; 358(9278):298-300. PubMed ID: 11498220
[TBL] [Abstract][Full Text] [Related]
19. Chromosome 1p allelic loss by fluorescence in situ hybridization is not observed in dysembryoplastic neuroepithelial tumors.
Prayson RA; Castilla EA; Hartke M; Pettay J; Tubbs RR; Barnett GH
Am J Clin Pathol; 2002 Oct; 118(4):512-7. PubMed ID: 12375636
[TBL] [Abstract][Full Text] [Related]
20. Use of monoclonal antibodies to glial fibrillary acidic protein in the cytologic diagnosis of brain tumors.
Chen Y; Zhang YX
Acta Cytol; 1989; 33(6):922-8. PubMed ID: 2588925
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
